Mankind Pharma Limited (NSE:MANKIND)
India · Delayed Price · Currency is INR 2,557.10
-49.70 (-1.91%)
Aug 25, 2025, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.08 trillion as of August 25, 2025. Its market cap has increased by 32.21% in one year.
Market Cap
1.08T
Enterprise Value
1.14T
Revenue
129.10B
Ranking
n/a
PE Ratio
56.16
Stock Price
2,557.10
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.08T, an increase of 88.84%. That is a compound annual growth rate of 31.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 1,075.90B | -9.46% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,939.23B |
| Divi's Laboratories | 1,600.24B |
| Cipla | 1,286.59B |
| Apollo Hospitals Enterprise | 1,139.71B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 705.43B |
| Alkem Laboratories | 648.28B |
| Aurobindo Pharma | 610.07B |